Gaal Lubor 4
4 · Timber Pharmaceuticals, Inc. · Filed Jul 6, 2021
Insider Transaction Report
Form 4
Gaal Lubor
Director
Transactions
- Award
Stock Option (right to buy)
2021-07-01+71,893→ 71,893 totalExercise: $1.18Exp: 2031-07-01→ Common Stock, par value $0.001 per share (71,893 underlying)
Footnotes (2)
- [F1]The option grant was approved by the compensation committee of the board of directors of Timber Pharmaceuticals, Inc. (the "Company") on April 21, 2021, subject to stockholder approval of an amendment to the Company's 2020 Omnibus Equity Incentive Plan (the "Amendment"). The Company's stockholders approved the Amendment on July 1, 2021.
- [F2]The option grant will vest in 24 equal monthly installments beginning on August 1, 2021.